Protein Alternatives receives the Innovative SME Seal

April 9th, 2021. PROALT has received the Innovative SME Seal, valid until April 2024. Innovation is one of the key factors for the economic and social development of any country. Through the Innovative SME Seal, the Ministry of Science and Innovation recognizes companies that carry out activities in the field of research, technological development and [...]

2021-05-04T11:07:52+00:009 April 2021|Tags: , , |

ProAlt’s MetasCure project selected in the R&D and innovation programme of Madrid Region

January 14th, 2021 Tres Cantos, Madrid, Spain. Protein Alternatives (PROALT), a leading company in the development of therapeutic monoclonal antibodies in oncology, has been selected as one of the two companies that will receive funding from the R&D and innovation programme of Madrid Region during 2021 and 2022. MetastCure project, with title “Preclinical evaluation of [...]

2021-05-04T11:08:46+00:0014 January 2021|Tags: , , , |

Protein Alternatives announces the opening of new office in Boston

December 1st, 2020 Tres Cantos, Madrid, Spain. Protein Alternatives (PROALT), a leading company in the development of diagnostic and therapeutic products in oncology and research services provider, announces today the opening of its new office in Boston at the Cambridge Innovation Center (CIC). United States is one of the priority markets for the organization and [...]

2020-12-01T11:29:02+00:001 December 2020|Tags: , |

PROALT participates in BIO-Europe® Digital

October 26th, 2020 BIO-Europe is the largest partnering conference in Europe dedicated to the global biotechnology industry. On this occasion, it will be held in digital format from October 26 to 29. The conference brings together delegates from the entire value chain of the biotech industry, who come to event to identify, negotiate and start [...]

2020-11-27T15:23:37+00:0026 October 2020|Tags: , |

PROALT participates in AseBio Investor Day 2020

September 28th, 2020 AseBio Investor Day 2020 is a digital event from September 28th to October 1st, organized by the Spanish Association of Bioempresas (AseBio), together with the Biotechnology Market Platform (Ministry of Science), Innovation and Universities, the Institute of Foreign Trade (ICEX) and the BioVoices project. PROALT will participate in the partnering event and [...]

2020-11-27T15:24:25+00:0028 September 2020|Tags: , |

PROALT attended the 9th International Biotechnology Meeting, BIOSPAIN 2018

1st, October 2018 From September 25 to 27, the meeting organized by ASEBIO and the Junta de Andalucía brought together in Seville the largest national and international agents in the biotechnology sector. PROALT has participated in the partnering event and met during these days with investors, customers and potential commercial and technological partners. The company [...]

2020-05-05T15:30:55+00:001 October 2018|Tags: , |

PROALT exhibits and presented at the investment forum in BIOSPAIN 2016

3rd, October 2016 PROALT has attended BIOSPAIN 2016. This year's event has been held from 28th to 31st September 2016 in Bilbao (Spain). PROALT participated with a booth at the exhibition area of BioSpain. PROALT also met other attendees during the business partnering and presented its business project at the Investment Forum.       [...]

2020-05-05T15:34:52+00:003 October 2016|Tags: , |

PROALT has been selected finalist in ‘The South Summit 2014’ startups competition

October 10th, 2014Protein Alternatives has been finalist in 'The South Summit' 2014. The company was selected within the 100 finalists from more than 3000 startups from Southern Europe and South America, and participated in the new global start up hub event THE SOUTH SUMMIT 2014 on October 8-10. COLODETECT, un proyecto presentado por la empresa [...]

2020-05-05T15:38:11+00:0010 October 2014|Tags: , , , |
Go to Top